antibiotics drugs. The recurrences occurred for three times, from 6 to 12 months from each other, on average, every 9 months. The histological examination showed the presence of inhomogeneous materials mainly composed by inflammatory and keratin cells due to a granulomatous reaction connected to a bacterial infection. At the ultrasound (US), there was a clear evidence of a fistula located between the lesion and the corpus spongiosus of the penis (15 × 20 mm) with remarkable edema and inflammation, which resulted in a light hypoechoic thickening of the skin's wall (Figs. 1, 2) . A penile Magnetic Resonance Imaging (MRI) was done for further investigation, but excluded a urethral fistula.
Introduction
The most common penile fistulas are urethrocutaneous fistulas due to inflammatory-infective processes, trauma, posturethral surgical complications, radiotherapy, ischemia, and malignancy or congenital urethra's malformations (1). We present a 39-year-old man with a rare case of cutaneousspongiosus fistula with recurrent episodes of cutaneous abscess treated with Hyperbaric Oxygen Therapy (HBOT).
Conclusions
Urological fistulas are a frequent surgical complication. Their treatment is based on the cause of the fistula, its position, its dimension, and its anatomic characteristics (1, 2).
Generally, for smaller and early-diagnosed fistulas, the treatment should be conservative, and it consists in adequate nutrition, antibiotic therapy, and the removal of the causes. When fistula is too extended or a conservative approach is not therapeutic, surgical treatment should be considered. However, in the recent years, there is a growing interest in the clinical applications for HBOT, especially in the healing of late radiation tissue injury (LRTI). Bennett et al performed a literature review of 753 participants affected by LRTI of deep tissue treated with HBOT and they concluded that HBOT might improve healing outcomes and its use can be justified (3). The HBOT therapeutic action seems to be related to the temporary suppression of the proinflammatory-induced stimulus, cytokine production, and it induces the liberation of TNF-alpha and endothelins. Furthermore, VEGF levels are significantly increased (4). Thereby, HBOT stimulates angiogenesis, fibroblasts function, granulation tissue formation, and determines anti-inflammatory upregulation of IL-8 and nitric oxide. It also improves the control of infections enhancing leukocytes function (5, 6). Tompach et al exposed cultured endothelial cells and fibroblasts to hyperbaric oxygen. So, they demonstrated growed proliferation of both cell types (7). Several investigators have researched the use of HBOT for treating chronic wounds in diabetic patients, including diabetic foot ulcers. In fact, Baroni et al reported, in a series of patients with diabetic foot gangrene, that those who underwent HBOT experienced a better healing outcome and were less likely to undergo foot amputation. Furthermore, the vasoconstriction induced due to hyperoxia, especially in superficial tissues, decreased edema in the periwound area (8) . Similarly, in our case, there was a significant reduction of edema after the first cycle of HBOT. Kolpen et al also demonstrated the potential effects of HBOT to improve the bactericidal capacities of the antibiotics and the ability to increase the oxidative burst through the production of oxygen radicals especially in superficial wounds, bone, and biliary ducts (9) . All these experiences confirm that HBOT provide optimal physiological conditions for wound healing.
In conclusion, our case suggests that HBOT is an effective treatment for chronic wounds when used in combination with conventional standard therapy or further interventions. At present time, the gold standard for the treatment of spongiosus-cutaneous fistulas remains surgery; nevertheless, our experience with HBOT may stimulate its use in further clinical trials. 
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